CLINICAL CHARACTERISTICS OF MYCOPLASMA PNEUMONIA IN HOSPITALIZED PATIENTS-Reference-Cited by-同舟云学术

CLINICAL CHARACTERISTICS OF MYCOPLASMA PNEUMONIA IN HOSPITALIZED PATIENTS

Published:2018-12-21 Issue:6 Volume:25 Page:83-89
ISSN:2541-9544
Container-title:Kuban Scientific Medical Bulletin
language:
Short-container-title:Kuban. nauсh. med. vestnik

Author:

Zhukova L. I.¹,Gorodin V. N.¹,Kovalevskaya O. I.²,Kozyreva E. V.²,Oleinikova E. S.¹

Affiliation:

1. Federal state budgetary educational establishment of higher education «the Kuban state medical university» Ministries of Health of the Russian Federation; The state budgetary establishment of public health services «Specialized clinical infectious hospital» Ministries of Health of Krasnodar territory.

2. The state budgetary establishment of public health services «Specialized clinical infectious hospital» Ministries of Health of Krasnodar territory.

Abstract

Aim.The research was designed for clinical and laboratory characteristics and treatment of respiratory mycoplasma pneumonia in adult patients hospitalized to the infectious diseases hospital of the city of Krasnodar.Materials and methods.The frequency of occurrence and the nature of the clinical symptoms confirmed by ELISA analysis of mycoplasma pneumonia in 35 patients, who were treated in the State Budgetary Establishment of Public Health Services “Specialized Clinical Infectious Hospital” of Krasnodar, were retrospectively analyzed.Results.Mycoplasma pneumonia in hospitalized patients of Krasnodar is more common in young men during the cold season and occurs in moderate form. When ranking the clinical symptoms, it has been established that the priority signs of the disease are acute onset, febrile temperature, symptoms of lesions of the upper respiratory tract, increased CRP, dry coughing and relative monocytosis in the general blood test that can be considered the suggestive symptoms of the disease. Antimicrobial drugs from the macrolide, fluorinated quinolone and tetracycline groups, either as a monotherapy or in the combination, were prescribed for the patients with mycoplasma pneumonia.Conclusion. The frequency of occurrence and the absence of pathognomonic symptoms of mycoplasma pneumonia make it advisable to include an enzyme immunoassay for antibodies to “atypical” pathogens in the examination algorithm of patients with any pneumonia, which will provide more accurate diagnosis and correction of etiotropic therapy.

Publisher

Kuban State Medical University

Subject

General Medicine

Reference19 articles.

1. Aver'janov A.V. Chlamydia and mycoplasma infections in pathology of the lower respiratory tract. Lechebnoe delo. 2009; 4:5 2-62. (In Russ., English abstract).

2. Lisin V.V., Korenjako I.E. Respiratornyj mikoplazmoz. М: 1988. 77 p. (In Russ.).

3. Deljagin V.M., Blohin B.M., Mel'nikova M.A., Mel'nikova M.B. Mycoplasma infection as an interdisciplinary problem. Lechebnoe delo. 2006; 4: 3-9. (In Russ., English abstract).

4. Morozova N.V., Ostrovskaja O.V., Holodok G.N., Morozova O.I., Nagovicyna E.B., Kozlov V.K. Clinical and epidemiological characteristics of mycoplasma pneumonia in children. Rossijskij vestnik perinatologii i pediatrii. 2012; 4(1): 50-54. (In Russ., English abstract).

5. Shhetinin E.V., Baturin V.A., Baturina M.V. Is there a need to estimate the prevalence and effectiveness of antimicrobials? Problems of standardization in health care. Problemy standartizacii v zdravoohranenii. 2012; 1-2: 47-50. (In Russ., English abstract).